Literature DB >> 20673202

Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke.

Cameron Rink1, Savita Khanna.   

Abstract

The significance of the hypoxia component of stroke injury is highlighted by hypermetabolic brain tissue enriched with arachidonic acid (AA), a 22:6n-3 polyunsaturated fatty acid. In an ischemic stroke environment in which cerebral blood flow is arrested, oxygen-starved brain tissue initiates the rapid cleavage of AA from the membrane phospholipid bilayer. Once free, AA undergoes both enzyme-independent and enzyme-mediated oxidative metabolism, resulting in the formation of number of biologically active metabolites which themselves contribute to pathological stroke outcomes. This review is intended to examine two divergent roles of molecular dioxygen in brain tissue as (1) a substrate for life-sustaining homeostatic metabolism of glucose and (2) a substrate for pathogenic metabolism of AA under conditions of stroke. Recent developments in research concerning supplemental oxygen therapy as an intervention to correct the hypoxic component of stroke injury are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20673202      PMCID: PMC3078506          DOI: 10.1089/ars.2010.3474

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  176 in total

Review 1.  Cytochrome P450 in the brain; a review.

Authors:  E Hedlund; J A Gustafsson; M Warner
Journal:  Curr Drug Metab       Date:  2001-09       Impact factor: 3.731

Review 2.  Cyclooxygenases: structural, cellular, and molecular biology.

Authors:  W L Smith; D L DeWitt; R M Garavito
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

3.  Evolution of brain infarction after transient focal cerebral ischemia in mice.

Authors:  R Hata; K Maeda; D Hermann; G Mies; K A Hossmann
Journal:  J Cereb Blood Flow Metab       Date:  2000-06       Impact factor: 6.200

Review 4.  Hemorrhagic transformation following ischemic stroke: significance, causes, and relationship to therapy and treatment.

Authors:  Paul A Lapchak
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

5.  Calcium-sensitive cytosolic phospholipase A2 (cPLA2) is expressed in human brain astrocytes.

Authors:  D T Stephenson; J V Manetta; D L White; X G Chiou; L Cox; B Gitter; P C May; J D Sharp; R M Kramer; J A Clemens
Journal:  Brain Res       Date:  1994-02-21       Impact factor: 3.252

6.  Syk activation is a leukotriene B4-regulated event involved in macrophage phagocytosis of IgG-coated targets but not apoptotic cells.

Authors:  Claudio Canetti; Bin Hu; Jeffrey L Curtis; Marc Peters-Golden
Journal:  Blood       Date:  2003-05-01       Impact factor: 22.113

7.  Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia.

Authors:  Yasemin Gürsoy-Ozdemir; Alp Can; Turgay Dalkara
Journal:  Stroke       Date:  2004-04-08       Impact factor: 7.914

8.  Platelet-activating factor (PAF) concentration and PAF acetylhydrolase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage.

Authors:  Y Hirashima; S Endo; T Ohmori; R Kato; A Takaku
Journal:  J Neurosurg       Date:  1994-01       Impact factor: 5.115

9.  MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke.

Authors:  Anna Rosell; Eloy Cuadrado; Arantxa Ortega-Aznar; Mar Hernández-Guillamon; Eng H Lo; Joan Montaner
Journal:  Stroke       Date:  2008-03-06       Impact factor: 7.914

10.  Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses.

Authors:  R S Byrum; J L Goulet; R J Griffiths; B H Koller
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

View more
  52 in total

Review 1.  MicroRNA in ischemic stroke etiology and pathology.

Authors:  Cameron Rink; Savita Khanna
Journal:  Physiol Genomics       Date:  2010-09-14       Impact factor: 3.107

2.  Sleep-disordered breathing and stroke: therapeutic approaches.

Authors:  Melissa C Lipford; John G Park; Kannan Ramar
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

3.  12/15-lipoxygenase expression is increased in oligodendrocytes and microglia of periventricular leukomalacia.

Authors:  Robin L Haynes; Klaus van Leyen
Journal:  Dev Neurosci       Date:  2013-04-20       Impact factor: 2.984

4.  Cannabis and Cannabinoid Biology in Stroke.

Authors:  Sang-Ho Choi; Yongshan Mou; Afonso C Silva
Journal:  Stroke       Date:  2019-08-01       Impact factor: 7.914

Review 5.  Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets.

Authors:  Yong Gu; Jianping Chen; Jiangang Shen
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-22       Impact factor: 4.147

6.  Inhibition of DPP-4 Activity and Neuronal Atrophy with Genistein Attenuates Neurological Deficits Induced by Transient Global Cerebral Ischemia and Reperfusion in Streptozotocin-Induced Diabetic Mice.

Authors:  Mithun Singh Rajput; Purnima Dey Sarkar; Nilesh Prakash Nirmal
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

Review 7.  Inducible glutamate oxaloacetate transaminase as a therapeutic target against ischemic stroke.

Authors:  Savita Khanna; Zachary Briggs; Cameron Rink
Journal:  Antioxid Redox Signal       Date:  2015-01-10       Impact factor: 8.401

Review 8.  Traumatic brain injury-associated coagulopathy.

Authors:  Jianning Zhang; Rongcai Jiang; Li Liu; Timothy Watkins; Fangyi Zhang; Jing-fei Dong
Journal:  J Neurotrauma       Date:  2012-10-31       Impact factor: 5.269

9.  Propensity of Withania somnifera to Attenuate Behavioural, Biochemical, and Histological Alterations in Experimental Model of Stroke.

Authors:  Abhilasha Sood; Aditya Kumar; Devinder K Dhawan; Rajat Sandhir
Journal:  Cell Mol Neurobiol       Date:  2015-12-30       Impact factor: 5.046

Review 10.  Membrane lipid interactions in intestinal ischemia/reperfusion-induced Injury.

Authors:  Emily Archer Slone; Sherry D Fleming
Journal:  Clin Immunol       Date:  2014-05-09       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.